| 引用本文:金德庄，陈一飞.美欧日仿制药审批评价制度[J].世界中医药,2018,(12):. |
|
| 美欧日仿制药审批评价制度 |
| Review on Approval System of Generic Drugs in the United States,Europe and Japan |
| 投稿时间：2018-10-22 |
| DOI：10.3969/j.issn.1673-7202.2018.12.060 |
| 中文关键词: 仿制药 审评 审批 制度 |
| English Keywords:Generic drugs Review Approval System |
| 基金项目:国家自然科学基金青年科学基金项目（81401216） |
|
| 摘要点击次数: 727 |
| 全文下载次数: 1474 |
| 中文摘要: |
| 为更好地理解我国的仿制药审评审批制度,本文综述了美国、欧盟及日本的仿制药审批制度,并对我国的仿制药审评审批制度改革进行了讨论与展望。 |
| English Summary: |
| In order to better understand our generic drug approval system in China,this paper briefly introduced the generic drug approval system of the United States,the European Union and Japan.Finally,the reform of generic drug approval system in China also has been discussed and prospected. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
